The forum will feature 20-minute presentations (including Q&A) from a curated selection of exciting start-up companies, all carefully selected through our screening processes. You will also see updated presentations from past presenting companies.
Inmedix is a medical diagnostics company pioneering the field of stress biology through its FDA-cleared CloudHRV platform. We unlock the missing link in clinical treatment by measuring how stress drives disease. By capturing precise data on autonomic nervous system function in just five minutes, Inmedix helps physicians personalize treatment and improve outcomes. With a scalable SaaS model and growing clinical evidence base, we’re building the future of stress-informed care.
BleedIO builds secure, scalable Bluetooth Low Energy (BLE) mesh networks that provide real-time tracking, monitoring, and environmental sensing—without relying on Wi-Fi, GPS, or the cloud. Unlike traditional systems, our technology operates entirely at the edge using a decentralized mesh infrastructure. That means no single point of failure, no cloud latency, and no expensive infrastructure upgrades.
Optina is an AI-guided clinical decision support solution that enables early-stage detection, diagnosis and monitoring of multiple degenerative diseases. Optina enables clinicians to efficiently diagnose and monitor at-risk patients, conduct pre- and post- comparative analysis on prognosis and the effect of treatment, and predict how patients will respond to therapy.
Mind Pharma, a Yale IP–backed biotech, develops next-gen psychedelic treatments for psychiatric and CNS disorders. Focus: depression, migraine, and cluster headaches. Its short-acting model improves scalability, offering less frequent dosing than J&J’s Esketamine. Proof of concept studies completed in 48 participants and more than 100 patients underway at Yale.